Diabetes Kongress 2022
zur Liste
Prof. Dr. Bernard Zinman
Bernard Zinman OC, MDCM, FRCPC, FACPProfessor of Medicine University of Toronto and Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, CanadaBernard Zinman is Professor of Medicine at the University of Toronto and the Stephen and Suzie Pustil Diabetes Research Scientist at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada. Dr Zinman completed his medical degree at McGill University, Montreal, Canada, where he also completed his postgraduate training in internal medicine. He undertook further training in endocrinology at the University of Toronto.Dr Zinman’s main research interests include the long-term complications of diabetes mellitus, the evaluation of new therapies for type 1 and type 2 diabetes, diabetes in Aboriginal communities, and studies directed at the prevention of diabetes.Dr Zinman is the recipient of numerous awards including the Charles H. Best Medal for Distinguished Service in the Cause of Diabetes (awarded to the DCCT Investigators), the Alois Beringer Lecture Award, the Frederick G. Banting Award and the Gerald S. Wong Service Award of the Canadian Diabetes Association (CDA). In 2006, he received the American Diabetes Association (ADA)’s Outstanding Physician Clinician Award, and in 2009 he was awarded the Lifetime Achievement Award from the CDA and the Novartis Prize in Diabetes. In November 2011, Dr Zinman was appointed to the Order of Canada, in recognition of his achievements in diabetes patient care and research. In May 2012, he received the Queen Elizabeth II Diamond Jubilee Medal. In 2019 he was promoted to Officer in the Order of Canada. In 2020 Dr Zinman received the Outstanding Achievement in Clinical Diabetes Research Award from the ADA. For the past 5 years, Thomson Reuters has ranked Dr Zinman as among the top 1% of researchers cited in their specific field. He has authored more than 550 publications in national and international journals.
University of Toronto, Mount Sinai Hospital Canada
  • Vortrag The Metamorphose of SGLT-2 Inhibitors Speaker
    Datum: 26.05.2022 , Zeit: 14:02 | Thema: Sonstiges
    Details
  • Vortrag Effects of empagliflozin on uric acid levels and gout: observations from the EMPA-REG OUTCOME trial Autor:in
    Datum: 27.05.2022 , Zeit: 10:44 | Thema: Poster
    Details